{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-057805","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2025-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.254534+00:00","generated_at":"2026-05-16T12:45:46.240255+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avantor appoints former GSK CFO Simon Dingemans to board effective Jan 2, 2026","bullets":["Simon Dingemans elected to board effective Jan 2, 2026, filling vacancy from Jonathan Peacock's Dec 31, 2025 resignation.","Dingemans served as CFO of GSK (2011-2019) and as Managing Director/Partner at Carlyle Group (2020-2022).","Standard non-employee director compensation: $95K annual cash retainer plus $210K RSU grant vesting May 6, 2026.","Dingemans also serves on boards of Vodafone Group, WPP plc, and Genomics Limited."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-057805","json":"https://secwatch.observer/filing/0001628280-25-057805.json","markdown":"https://secwatch.observer/filing/0001628280-25-057805.md","text":"https://secwatch.observer/filing/0001628280-25-057805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000162828025057805/0001628280-25-057805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000162828025057805/avtr-20251217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:45:46.240255+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}